First Horizon Advisors, Inc. Alkermes Plc. Transaction History
First Horizon Advisors, Inc.
- $3.58 Billion
- Q3 2024
A detailed history of First Horizon Advisors, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 16 shares of ALKS stock, worth $490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$490
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
182MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$893 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$582 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$399 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$388 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$282 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.04B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...